Dr. Jerome is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ambulatory Clinic
825 Eastlake Avenue East
Seattle, WA 98109Phone+1 206-288-1000
Education & Training
Duke University School of MedicineClass of 1993
Certifications & Licensure
WA State Medical License 1998 - 2025- American Board of Pathology Clinical Pathology
Clinical Trials
- Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE) Start of enrollment: 2020 Dec 15
Publications & Presentations
PubMed
- 69 citationsCytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation.Danniel Zamora, Elizabeth R. Duke, Hu Xie, Bradley C. Edmison, Brenda Akoto
Blood. 2021-07-08 - 177 citationsPoint-of-care testing for COVID-19 using SHERLOCK diagnosticsJulia Joung, Alim Ladha, Makoto Saito, Michael Segel, Robert Bruneau
Medrxiv. 2020-05-08 - 37 citationsEvaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.Mars Stone, Eduard Grebe, Hasan Sulaeman, Clara Di Germanio, Honey Dave
Emerging Infectious Diseases. 2022-03-01
Journal Articles
- RNA Sequencing of the in Vivo Human Herpesvirus 6B Transcriptome to Identify Targets for Clinical Assays Distinguishing Between Latent and Active InfectionsJoshua A Hill, Keith R Jerome, Michael Boeckh, mBio
- Viral Genetics Modulate Orolabial HSV-1 Shedding in HumansAlex L Greninger, Eric Strachan, Keith R Jerome, David M Koelle, The Journal of Infectious Diseases
Authored Content
- Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1-April 16, 2020May 2020
Press Mentions
Mercer Island MD: ‘People Are Going to Get Tired of Getting Vaccines’April 11th, 2022- UW Medicine Study Seeks Local Participants to Understand COVID SpreadOctober 23rd, 2021
- City of Seattle Testing Locations Administer One Million COVID-19 TestsSeptember 14th, 2021
- Join now to see all
Grant Support
- Targeted Modification Of Host And Proviral DNA To Treat Latent HIV InfectionNational Institute Of Allergy And Infectious Diseases2011
- Targeted Disruption Of Integrated SHIV By Engineered Homing EndonucleasesNational Institute Of Allergy And Infectious Diseases2011
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2011
- Mechanisms Of Inactivation Of T Cells By HSVNational Institute Of Allergy And Infectious Diseases2006
- Inactivation Of CTL By Hsv-Infected CellsNational Institute Of Allergy And Infectious Diseases2004–2005
- Inhibition Of CTL Killing By HSVNational Institute Of Allergy And Infectious Diseases2001–2005
- Herpes Simplex Virus Inhibition Of CTL Induced ApoptosisNational Institute Of Allergy And Infectious Diseases1998–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
